Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis

Annals of Hematology

Volumn 78, Issue 10, 1999, Pages 437-444

  Le Bousse Kerdiles M C ^a   Martyre M C ^b  

^a HÔPITAL PAUL BROUSSE   (France)

^b INSTITUT CURIE   (France)

Author keywords

Cytokines; Fibrosis; Myelofibrosis; Myeloid metaplasia; Myeloproliferation; Pathogenesis

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CD34 ANTIGEN; CYTOKINE; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; FIBROBLAST; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; MEGAKARYOCYTE; MYELOFIBROSIS; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STEM CELL;

CYTOKINES; FIBROBLAST GROWTH FACTOR 2; HUMANS; MYELOFIBROSIS; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDERS; PLATELET-DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032701822     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050595     Document Type: Review

References (100)

1. Abboud SL, Pinzani M (1991) Peptide growth factors stimulate macrophage colony-stimulating factor in murine stromal cells. Blood 78:103-109
2. Alexander WS, Roberts AW, Nicola NA, Li R, Metcalf D (1996) Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-Mpl. Blood 87:2162-2170
3. Allouche M (1995) Basic fibroblast growth factor and hematopoiesis. Leukemia 9:937
4. Allouche M, Bayard F, Clamens S, Fillola G, Sié P, Almaric F (1995) Expression of basic fibroblast growth factor (bFGF) and FGF receptors in human leukemic cells. Leukemia 9:77-86
5. Apaja-Sarkkinen M, Autio-Harmainen, Alavaikko M, Risteli J, Risteli L (1986) Immunohistochemical study of basement membrane proteins and type III procollagen in myelofibrosis. Br J Haematol 63:571-580
6. Armstrong E, Vainikka S, Partanen J, Korhonen J, Alitalo R (1992) Expression of fibroblast growth factor receptors in human leukemia cells. Cancer Res 52:2004-2007
7. Avivi A, Zimmer Y, Yagon A, Yarden Y, Givol D (1991) Flg-2, a new member of the family of fibroblast growth factor receptors. Oncogene 6:1089-1092
8. Avraham H, Banu N, Scadden DT, Abraham J, Groopman JE (1994) Modulation of megakaryocytopoiesis by human basic fibroblast growth factor. Blood 83:2126-2132
9. Battegay EJ, Thomssen C, Nissen C, Gudat F, Speck B (1989) Endogenous megakaryocyte colonies from peripheral blood in precursor cell. Eur J Haematol 42:321-326
10. Brogi E, Wu T, Namiki A, Isner JM (1994) Indirect angiogenic cytokines up-regulate VEGF and bFGF gene expression in vascular smooth muscle cells whereas hypoxia upregulates VEGF expression only. Circulation 90:649-652
11. Brunner G, Nguyen H, Gabrilove JL, Rifkin DB, Wilson EL (1993) Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells. Blood 81:631-638
12. Bruno E, Cooper RJ, Wilson EL, Gabrilove JL, Hoffman R. (1993) Basic fibroblast growth factor promotes the proliferation of human megakaryocyte progenitor cells. Blood 82:430-435
13. Buschle M, Janssen JWG, Drexler H, Lyons T, Anger B, Bartram CR (1988) Evidence for pluripotent stem cell origin of idiopathic myelofibrosis: clonal analysis of a case characterized by an N-ras gene mutation. Leukemia 2:658-660
14. Cashman JD, Eaves AC, Raines EW, Ross R, Eaves CJ (1990) Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-β. Blood 75:96-101
15. Castro-Malaspina H (1984) Pathogenesis of myelofibrosis: role of ineffective megakaryopoiesis and megakaryocyte components. In: Myelofibrosis and the biology of connective tissue. Alan R. Liss, New York, pp 427-454
16. Castro-Malaspina H, Rabbelino EM, Yen A, Nachman RL, Moore MA (1981) Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood 57:781-787.
17. Chikkappa G, Carsten AL, Chanana AD, Chandra P, Cronkite EP (1978) Increased granulocytic, erythrocytic and megakaryocytic progenitors in myelofibrosis with myeloid metaplasia. Am J Hematol 4:121-131
18. Cocault L, Le Bousse-Kerdilès C, Flon M, Challier C, Clay D, Martyré MC, Souyri M (1998) TPO, c-mpl and megakaryocytes in idiopathic myelofibrosis. European Working Group on Myeloproliferative disorders of the European Haematology Association, Rotterdam, March 12-14, 1998 (abstract)
19. Dalley A, Smith JM, Reilly JT, MacNeil S (1996) Investigation of calmodulin and basic fibroblast growth factor (bFGF) in idiopathic myelofibrosis: evidence for a role of extracellular calmodulin in fibroblast proliferation. Br J Haematol 93:856-862
20. Dameshek W (1951) Some speculations on the myeloproliferative syndromes. Blood 6:372-376
21. DeCoteau JF, Knaus PI, Yankelev H, Reis MD, Lowsky R, Lodish HF, Kadin ME (1997) Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 94:5877-5881
22. Dionne CA, Crumley G, Bellot F, Kaplow JM, Searfoss G, Ruta M, Burgess WH, Jaye M, Schlessinger J (1990) Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J 9:2685-2692
23. Douay L, Laporte JP, Lefrançois G, Najman A, Dupuy-Montbrun MC, Lopez M, Giarratana MC, Gorin NC (1978) Blood and spleen haematopoiesis in patients with myelofibrosis. Leuk Res 8:725-730
24. Douer D, Fabian I, Cline MJ (1983) Circulating pluripotent haemopoietic cells in patients with myeloproliferative disorders. Br J Haematol 54:373-381
25. Eastham JM, Reilly JT, MacNeil S (1994) Raised urinary calmodulin levels in idiopathic myelofibrosis: possible implications for the aetiology of fibrosis. Br J Haematol 86:668-670
26. Eaves C, Udomsakdi C, Cashman J, Barnett M, Eaves A (1993) The biology of normal and neoplastic stem cells in CML. Leuk Lymphoma 11:245-253
27. Edwards DR, Murphy G, Reynolds JJ, Whitman SE, Docherty AJP, Angel P, Heath JK (1987) Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6:1899-1904
28. Fafeur V, Terman BI, Blum J, Böhlen P (1990) Basic FGF treatment of endothelial cells down-regulates the 85-KDa TGFb receptor subtype and decreases the growth inhibitory response to TGF-β1. Growth Factors 3:237-245
29. Gabbianelli M, Sargiacomo M, Pelosi E, Testa U, Isacchi G, Peschle C (1990) "Pure" human hematopoietic progenitors: permissive action of basic fibroblast growth factor. Science 249:1561-1564
30. Gabrilove JL, Wong G, Bollenbacher E, White K, Kojima S, Wilson EL (1993) Basic fibroblast growth factor counteracts the suppressive effect of transforming growth factor-β1 on human myeloid progenitor cells. Blood 81:909-915
31. Gabrilove JL, White K, Rahman Z, Wilson EL (1994) Stem cell factor and basic fibroblast growth factor are synergistic in augmenting committed myeloid progenitor cell growth. Blood 83:907-910
32. Gallicchio VS, Hughes NK, Hulette BC, DellaPuca R, Noblitt L (1991) Basic fibroblast growth factor (bFGF) induces early and late-stage hematopoietic progenitor cell colony formation (CFU-gm, CFU-meg, and BFUe) by synergizing with GM-CSF, Meg-CSF, and erythropoietin, and is a radioprotective agent in vitro. Int J Cell Cloning 9:220-232
33. Gilbert HS, Praloran V, Stanley ER (1989) Increased CSF-1 (M-CSF) in myeloproliferative disease: association with myeloid metaplasia and peripheral bone marrow extension. Blood 74:1231-1234
34. Groopman JE (1980) The pathogenesis of myelofibrosis in myeloproliferative disorders. Haematol Med 92:857-858
35. Han ZC, Brière J, Nedellec G, Algrall JF, Sensobe L, Parent D, Guern G (1988) Characteristics of circulating megakaryocyte progenitors (CFU-MK) in patients with primary myelofibrosis. Eur J Haematol 40:130-135
36. Han ZC, Bellucci S, Wan HY, Caen JP (1992) New insights into the regulation of megakaryocytopoiesis by haemopoietic and fibroblastic growth factors and transforming growth factor beta-1. Br J Haematol 81:1-5
37. Hasselbalch HC (1993) Idiopathic myelofibrosis. Clinical aspects and studies on extracellular matrix metabolism. Dan Med Bulletin 40:39-55
38. Hatzfeld J, Li M, Brown EL, Sookdeo H, Levesque JP, O'Toole T, Gurney C, Clark SC, Hatzfeld A (1991) Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor b1 or Rb oligonucleotides. J Exp Med 174:925-929
39. Heuck G (1879) Zwei Fälle von Leukämie mit eigenthümlichem Blut-resp. Knochenmarksbefund. Virchows Archiv A 79:475-496
40. Hibbin JA, Njoku OS, Matutes E, Lewis SM, Goldman JM (1984) Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders. Br J Haematol 57:495-503
41. Hino M, Tojo A, Miyazono K, Urabe A, Takaku F (1988) Effects of type β transforming growth factors on haematopoietic progenitor cells. Br J Haematol 70:143-147
42. Holyoake TL, Freshney MG, Sproul AM, Richmond LJ, Steward WP, Fitzsimons E, Dunlop DJ, Franklin IM, Prganell IB (1993) Contrasting effects of rh-MIP-1 alpha and TGF-beta 1 on chronic myeloid leukemia progenitors in vitro. Stem Cells 11:122-128
43. Hooper CW (1991) The role of transforming growth factor-beta in hematopoiesis. A review. Leuk Res 15:179-184
44. Horikawa Y, Matsumura J, Hashimoto K, Shiraga M, Kosugi S, Tadokoro S, Kato T, Miyazaki H, Tomiyama Y, Kurata Y, Matsuzawa Y, Kanakura Y (1997) Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia. Blood 90:4031-4038
45. Ignotz R, Massague J (1986) Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261:4337-4345
46. Jacobson RJ, Salo A, Fialkow PJ (1978) Agnogenic myeloid metaplasia: a clonal proliferation of haematopoietic stem cells with secondary myelofibrosis. Blood 51:189-194
47. Kahn A, Bernard JF, Cottreau D, Marie J, Bovin P (1975) A G-6-PD variant with heterozygous expression in blood cells of a woman with primary myelofibrosis. Humangenetik 30:41-46
48. Kiladjian JJ, Elkassar N, Hetet N, Brière J (1997) Study of the thrombopoietin receptor in essential thrombocythemia. Leukemia 11:1821-1826
49. Kimura A, Katoh O, Kuramoto A (1988) Effects of platelet derived growth factor, epidermal growth factor and transforming growth factor-β on the growth of human marrow fibroblasts. Br J Haematol 68:9-12
50. Klagsbrun M (1989) The fibroblast growth factor family: structural and biological properties. Prog Growth Factor Res 1:207-235
51. Kobayashi S, Teramura M, Hoshino S, Motoji T, Oshimi K, Mizoguchi H (1993) Circulating megakaryocyte progenitors in myeloproliferative disorders are hypersensitive to interleukin-3. Br J Haematol 83:539-544
52. Kreipe H, Jacquet K, Feigner J, Radzun HJ, Parwaresch MR (1991) Clonal granulocytes and bone marrow cells in the cellular phase of agnogenic myeloid metaplasia. Blood 78:1814-1817
53. Lagneaux L, Delforge A, Bron D, Massy M, Bernier M, Stryckmans P (1997) Heterogenous response of B lymphocytes to transforming growth factor-beta in B-cell chronic lymphocytic leukaemia: correlation with the expression of TGF-beta receptors. Br J Haematol 97:617-620
54. Laiho M, Saksela O, Keski-Oja J (1987) Transforming growth factor-β induction of type-1 plasminogen activator inhibitor. J Biol Chem 262:17467-17474
55. + human hematopoietic progenitor cells through different cell kinetic mechanisms depending on the applied stimulus. Exp Hematol 22:903-909
56. Lazlo J (1975) Myeloproliferative myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD and hemorrhagic thrombocythemia. Semin Hematol 12:409-432
57. Le Bousse-Kerdilès M.C, Smadja-Joffe F, Klein B, Caillou B, Jasmin C (1980) Study of a virus-induced myeloproliferative syndrome associated with tumor formation in mice. Eur J Cancer 16:43-51
58. Le Bousse-Kerdilès MC Souyri M, Smadja-Joffe F, Praloran V, Jasmin C, Zittener HJ (1992) Enhanced hematopoietic growth factor production in an experimental myeloproliferative syndrome. Blood 79:3179-3187
59. + hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia. Blood 88:4534-4546
60. Li M, Hatzfeld A, Brown EL, Sookdeo H, Panterne B, Levesque JP, O'Toole T, Clark SC, Hatzfeld J (1991) Autocrine transforming growth factor-β controls Go phase of early human hematopoietic progenitors in serum or serum-free culture. In: Murphy MJ jr (ed) Blood cell growth factors. Proc Beijing Symposium. AlphaMed, Dayton,pp 228-232
61. Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF (1992) Expression cloning of the TGF-β-type II receptor, a functional transmembrane serine/threonine kinase. Cell 68:775-785
62. Lok S, Kaushansky K, Holly RD, Kujiper JL, Lofton-Day CE, Oort PJ, Grant FJ, Heipel MD, Burkhead SK, Kramer JM, Bell LA, Sprecher CA, Blumberg H, Johnson R, Prunkard D, Ching AFT, Mathewes SL, Beiley MC, Forstrom JW, Buddle MM, Osborn SG, Evans SJ, Shezppard PO, Presnell SR, O'Hara PJ, Hagen FS, Roth GJ, Foster DC (1994) Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369:565-568
63. Lopez-Casillas F, Cheifetz S, Doody J, Andres JL, Lane WS, Massagué J (1991) Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system. Cell 67:785-795
64. Martyré MC (1991) Platelet PDGF and TGF-β levels in myeloproliferative disorders. Leuk Lymphoma 6:1-6
65. Martyré MC, Magdelenat H, Bryckaert MC, Laine-Bidron C, Calvo F (1991) Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-β in patients with myelofibrosis with myeloid metaplasia. Br J Haematol 77:80-86
66. Martyré MC, Romquin N, Le Bousse-Kerdilès C, Chevillard S, Benyahia B, Dupriez B, Demory JL, Bauters F (1994) Transforming growth factor-β and megakaryocytes in the pathogenesis of idiopathic myelofibrosis. Br J Haematol 88:9-16
67. Martyré MC, Le Bousse-Kerdilès C, Romquin N, Chevillard S, Praloran V, Demory JL, Dupriez B (1997) Elevated levels of basic growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis. Br J Haematol 97:441-448
68. Massague J (1990) The transforming growth factor-β family. Ann Rev Cell Biol 6:597-641
69. Menzel T, Rahman Z, Calleja E, White K, Wilson EL, Wieder R, Gabrilove JL (1996) Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine. Blood 87:1056-1063
70. Methia N, Louache P, Vainchenker W, Wendling F (1993) Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood 82:1385-1401
71. Mignatti P, Rifkin DB (1991) Release of basic fibroblast growth factor, and angiogenic factor devoid of secretory signal sequence: a trivial phenomenon or a novel secretion mechanism. J Cell Biochem 47:201-207
72. Moliterno A, Hankins W, Spivak J (1998) Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med 338:572-580
73. Moscatelli D (1988) Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells. J Cell Biol 107:753-759
74. Novetsky A, Wang JC, Chen C (1997) Plasma VEGF levels in patients with primary myelofibrosis and other myeloproliferative disorders. Blood 90:(abstract)
75. Oliver LJ, Rifkin DB, Gabrilove JL, Hannocks MJ, Wilson EL (1990) Long-term culture of human bone marrow stromal cells in the presence of basic fibroblast growth factor. Growth Factors 3:231-236
76. Pearson CA, Pearson D, Shibahara S, Hofsteenge J, Chiquet-Ehrismann R (1988) Tenascin: cDNA cloning and induction by TGF-β. EMBO J 7:2977-2981
77. Rameshwar P, Denny TN, Stein D, Gascon P (1994) Monocyte adhesion in patients with bone marrow fibrosis is required for the production of fibrogenic cytokines. Potential role for interleukin-1 and TGF-β. J Immunol 153:2819-2830
78. Reilly JT, Nash JGR (1988) Vitronectin (serum spreading factor): its localisation in normal and fibrotic tissue. J Clin Pathol 59:1269-1272
79. Reilly JT, Nash JGR, Mackie MJ, McVerry BA (1985) Immunoenzymatic detection of fibronectin in normal and pathological haematopoietic tissue. Br J Haematol 59:497-504
80. Reilly JT, Barnett D, Dolan G, Forrest P, Eastham J, Smith A (1993) Characterisation of an acute micromegakaryocytic leukaemia: evidence for the pathogenesis of myelofibrosis. Br J Haematol 83:58-62
81. Sato Y, Suda T, Suda J (1986) Multilineage expression of haemopoietic precursors with abnormal clone in idiopathic myelofibrosis. Br J Haematol 64:657-667
82. Sing GK, Keller JR, Ellingsworth LR, Ruscetti FW (1988) Transforming growth factor b selectively inhibits normal and leukemic human bone marrow cell growth in vitro. Blood 72:1504-1511
83. Smadja-Joffe F, Legras S, Li Y, Girard N, Delpech B, Morimoto K, Le Bousse-Kerdilès C, Jasmin C, Levesque JP (1996) CD44 and hyaluronan binding by human myeloid cells. Leuk Lymphoma 21:407-420
84. Soini Y, Kamel D, Apaja-Sarkkinen M, Virtanen L, Lehto VP (1993) Tenascin immunoreactivity in normal and pathological bone marrow. J Clin Pathol 46:218-221
85. Terui T, Niitsu Y, Mahara K, Fujisaki Y, Urushizaki Y, Mogi Y, Kohgo Y, Watanabe N, Ogura M, Saito H (1990) The production of transforming growth factor-β in acute megakaryoblastic leukemia and its possible implication in myelofibrosis. Blood 75:1540-1548
86. Thiele J, Fischer R (1991) Megakaryocytopoiesis in haematological disorders: diagnostic features of bone marrow biopsies. Virchows Archiv A Pathol Anat Histopathol 418:87-97
87. Thiele J, Kuemmel T, Sander C, Fisher R (1991) Ultrastructure of the bone marrow tissue in so-called primary (idiopathic) myelofibrosis-osteomyelosclerosis (agnogenic myeloid metaplasia). I. Abnormalities of megakaryopoiesis and thrombocytes. J Subsmicrosc Cytol Pathol 23:93-107
88. Thiele J, Braeckel C, Wagner S (1992) Macrophages in normal human bone marrow and in chronic myeloproliferative disorders: an immunohistochemical and morphometric study by a new monoclonal antibody (PG-M1) on trephine biopsies. Virchows Archiv A Pathol Anat Histopathol 421:33-39
89. Tsai JC, Goldman CK, Gillepsie GY (1995) Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. J Neurosurg 82:864-873
90. Vigon I, Mornon JP, Cocault L, Mitjavila MT, Tambourin P, Gisselbrecht S, Souyri M (1992) Molecular cloning and characterization of MPL, the human homolog of the v-mpl; oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci U S A 89:5640-5644
91. Villeval JL, Cohen-Solal K, Tulliez M, Giraudier S, Guichard J, Burstein SA, Cramer EM, Vainchenker W, Wendling F (1997) High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice. Blood 90:4369-4383
92. Wang JC, Lang HD, Lichter S, Weinstein M, Benn P (1992) Cytogenetic studies of bone marrow fibroblasts cultured from patients with myelofibrosis and myeloid metaplasia. Br J Haematol 80:184-188
93. Wang JC, Chen C, Lou LH, Mora M (1997) Blood thrombopoietin, IL-6 and IL-11 levels in patients with agnogenic myeloid metaplasia. Leukemia 11:1827-1832
94. Ward HP, Block MH (1971) The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine 50:357-420
95. Wehmeier A, Sudhoff T (1997) Elevated plasma levels of basic fibroblast growth factor in patients with essential thrombocythaemia and polycythaemia vera. Br J Haematol 98:1050-1051
96. Wilson EL, Rifkin DB, Kelly F, Hannocks MJ, Gabrilove JL (1991) Basic fibroblast growth factor stimulates myelopoiesis in long-term human bone marrow cultures. Blood 77:954-960
97. Wolf BC, Neiman RS (1987) Hypothesis: splenic filtration and the pathogenesis of extramedullary hematopoiesis in agnogenic myeloid metaplasia. Human Pathol 1:77-80
98. Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J (1994) Mechanism of activation of the TGF-β receptor. Nature 370:341-347
99. Yan XQ, Lacey D, Hill D, Chen Y, Fletcher F, Hawly RG, McNiece IK (1996) A model of myelofibrosis and osteomyelosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation. Blood 88:402-409
100. Zauli G, Visani G, Catani L, Vianelli N, Gugliotta L, Capitani S (1993) Reduced responsiveness of bone marrow megakaryocyte progenitors to platelet-derived transforming growth factor β1, produced in normal amounts, in patients with essential thrombocythaemia. Br J Haematol 83:14-20